KMID : 0380220070400050731
|
|
Journal of Biochemistry and Molecular Biology 2007 Volume.40 No. 5 p.731 ~ p.739
|
|
Preparation and Characterization of Paclitaxel-loaded PLGA Nanoparticles Coated with Cationic SM5-1 Single-chain Antibody
|
|
Kou Geng
Gao Jie Wang Hao Chen Huaiwen Li Bohua Zhang Dapeng Wang Shuhui Hou Sheng Qian Weizhu Dai Jianxin Zhong Yanqiang Guo Yajun
|
|
Abstract
|
|
|
The purpose of this study was to develop paclitaxel-loaded poly(lactide-co-glycolide) (PLGA) nanoparticles coated with cationic SM5-1 single-chain antibody (scFv) containing a polylysine (SMFv-polylys). SM5-1 scFv (SMFv) is derived from SM5-1 monoclonal antibody, which binds to a 230 kDa membrane protein specifically expressed on melanoma, hepatocellular carcinoma and breast cancer cells. SMFv-polylys was expressed in Escherichia coli and purified by cation-exchange chromatography. Purified SMFv-polylys was fixed to paclitaxel-loaded PLGA nanoparticles to form paclitaxel-loaded PLGA nanoparticles coated with SMFv-polylys (Ptx-NP-S). Ptx-NP-S was shown to retain the specific antigen-binding affinity of SMFv-polylys to SM5-1 binding protein-positive Ch-hep-3 cells. Finally, the cytotoxicity of Ptx-NP-S was evaluated by a non-radioactive cell proliferation assay. It was demonstrated that Ptx-NP-S had significantly enhanced in vitro cytotoxicity against Ch-hep-3 cells as compared with non-targeted paclitaxel-loaded PLGA nanoparticles. In conclusion, our results suggest that cationic SMFv-polylys has been successfully generated and may be used as targeted ligand for preparing cancer-targeted nanoparticles.
|
|
KEYWORD
|
|
Nanoparticles, Paclitaxel, PLGA, Single-chain antibody, SM5-1
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|